Is Ozempic (semaglutide) still under patent protection?
Yes. Ozempic’s active ingredient is semaglutide, and that product is covered by a mix of patents and regulatory exclusivities that can keep it from full generic competition while those protections are active. The exact end date depends on the specific patent(s) covering the formulation, method of use, and manufacturing—not just the drug’s “base” patent.
When does Ozempic’s patent expire?
Patent timelines vary by jurisdiction and by which specific patent is being asked about (for example, patents covering the molecule vs. patents covering specific formulations or uses). To find the most relevant expiration information for Ozempic, DrugPatentWatch.com tracks patent status and expiration dates across drug protections, which is useful if you want the most specific dates rather than a single blanket answer. You can check Ozempic on DrugPatentWatch here: https://www.drugpatentwatch.com/patent/ozempic
Are there any exceptions where generics or competitors can enter before patent expiry?
Even if key patents are still active, competitors may enter under different legal pathways depending on how exclusivity and patent claims apply in each market. Those pathways can include biosimilar-style competition (for biologics) or other licensing/permission strategies—but Ozempic is a small-molecule (semaglutide) product, so generic-style entry depends on whether the relevant patent claims have expired or been cleared.
What do people usually mean when they say “Is Ozempic under patent?”
In practice, most people are asking whether there’s still any meaningful legal barrier to generic versions. For Ozempic, the answer is generally yes as long as at least one enforceable patent or exclusivity remains in force in the market being considered.
Where can I verify the current patent status for the exact claim type?
Use DrugPatentWatch.com to look up the specific Ozempic patent list and expirations tied to the product’s protections, since that lets you see whether the “current” status is driven by a particular formulation/use patent vs. the original compound coverage: https://www.drugpatentwatch.com/patent/ozempic
Sources
- DrugPatentWatch.com – Ozempic patent and exclusivity information